Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board
March 13, 2024
March 13, 2024
Anh Nguyen stepped down from MedinCell Supervisory Board as Member and Chairman Due to Statutory Age Limit
February 19, 2024
February 19, 2024
MedinCell to present at the Evercore ISI 2024 Emerging Biotech Conference
February 15, 2024
February 15, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK)
January 31, 2024
January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK
January 9, 2024
January 9, 2024
Jefferies initiates MedinCell’s coverage with a “Buy” recommendation
January 4, 2024
January 4, 2024
Half-Year results (April 2023 – September 2023)
December 19, 2023
December 19, 2023
MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program
November 13, 2023
November 13, 2023
MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November
November 6, 2023
November 6, 2023
MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model
